麻豆传媒

Devoney Looser is an expert on 18th and 19th-century British literature, women鈥檚 writings, and Jane Austen.

She is the author or editor of seven books on literature by women and a 2018 Guggenheim Fellow and NEH Public Scholar. Her most recent book, "The Making of Jane Austen" (Johns Hopkins University Press, 2017), was a Publishers Weekly Best Summer Book (Nonfiction) and received the Inside Higher Ed Reader鈥檚 Choice Award. 

She is a Foundation Professor of English and in conjunction with ASU's Global Sport Institute, she is working on a book-length project that tracks the history of roller derby, a sport she participates in occasionally as faculty advisor for the ASU Roller Derby club team. 

Looser鈥檚 essays have appeared in The New York Times, The Atlantic, Salon, and the TLS. She writes regularly on professional issues for The Chronicle of Higher Education. She's been a quoted authority about Jane Austen for CNN, The New York Times, USA Today, and the Wall Street Journal.

Jan Kitajewski, PhD,  is the Director of the University of Illinois Cancer Center and head of the Department of Physiology and Biophysics at the University of Illinois Chicago (UIC).

His research is focused on tumor angiogenesis, cell fate determination, GPCR signaling and pathway remodeling. His specific areas of focus are vessel development, reproductive angiogenesis and tumor angiogenesis associated with breast and ovarian cancer. His lab established that Notch functions in tumor angiogenesis and developed therapeutic strategies to treat gynecological malignancies and breast cancer.

Kitajewski received his PhD from Princeton University. Previously, he served at Columbia University as Co-Director of the Cancer Signaling Networks program at Herbert Irving Comprehensive Cancer Center (HICCC) and Director of the Division of Reproductive Sciences in the Department of Ob/Gyn.

Julie Sacks currently serves as President and Chief Operating Officer (COO) of the Home
Centered Care Institute (HCCI), a national non-profit focused聽on advancing home-based primary
care to ensure that chronically ill, medically complex, and the more than 7 million people who
are homebound or home-limited have access to high-quality care in their home.

As President and COO, Sacks plays an integral role in evaluating strategic opportunities and
partnerships, developing relationships with donors and foundations, and serving as
spokesperson. Since she joined HCCI, the organization has made significant strides toward
creating universal access to house call programs.

Julie has been with HCCI since 2015. She previously served as vice president of operations and
advancement where she orchestrated the development and implementation of the
organization鈥檚 annual plan and strategic three-year roadmap while managing HCCI鈥檚 executive
team, oversaw daily operations, and served as the primary liaison to the HCCI board of
directors.

Prior to joining HCCI, Sacks was senior director of programs and services of the National Young
Onset Center for the American Parkinson Disease Association. She graduated with a bachelor鈥檚
degree in advertising from the University of Texas at Austin. After working in marketing for
almost 10 years, she earned a master鈥檚 degree in social work from the University of Texas at
Arlington.

Greg Autry is an expert in entrepreneurship, macroeconomics and space policy.

His research focuses on governmental roles in the emergence of new industries especially within the global commercial space industry.

Professor Autry teaches space leadership, policy and business in the Thunderbird School of Global Management. 

He has been a notable advocate for space exploration and development, serving as Chair of the Safety Working Group in the FAA Commercial Space Transportation Advisory Committee (COMSTAC), and as vice president of the National Space Society and the Beyond Earth Institute. 

Dennis Hoffman closely studies the regional economy in Arizona and conducts economic research for most major businesses across the state, several state agencies and numerous foundations.

Hoffman is the Director of the L. William Seidman Research Institute at the W. P. Carey School of Business and Director of ASU鈥檚 Office of the University Economist. 

His work includes the construction and maintenance of the tax revenue forecasting model used by the state of Arizona鈥檚 Executive Budget Office each year since 1982. 

Hoffman's research interests include defining and measuring the role of research universities in regional development, quantifying the value of education investments to the economic prosperity of a region, and measuring the impact of various fiscal initiatives on regional development.

Arvind Varsani is a molecular virologist who works across ecosystems from plants to animals and from the tropics to polar regions. 

Arvind Varsani and his collaborators have focused on addressing the diversity, demographics and evolutionary dynamics of viral communities in various ecosystems. Studies in the last decade have shown that viruses are the most common and abundant entities on earth, yet very little is known about their evolution and ecosystem roles. 

Our current knowledge of viruses is heavily biased to those that cause disease in humans, animals and plants. This equates to a very small portion of the viral diversity on the planet and a very minute fraction of the virome associated with humans, animals and plants.

His broad research objectives are to: 1) study viral dynamics in Antarctica ecosystem, the least human-altered marine system on the planet 2) unravel the viral evolutionary dynamics as a consequence of climate change; 3) study viral ecological interaction networks within a microbiome and more broadly within phytobiomes in order to unravel the dynamics of pathogen emergence.

Dr. Alderuccio is a board-certified Hematologist-Oncologist, and specializes in the treatment of patients diagnosed with lymphoma. He also conducts clinical research focused on expanding the treatment repertoire for patients diagnosed with various lymphomas.

Dr. Alderuccio research efforts are geared toward improving and expanding the treatment options available for patients diagnosed with both aggressive and indolent lymphomas. In particular, he is interested in the development of novel, targeted therapies which hinges on the use of genetic sequencing technology. His current research is aimed at identifying clinical characteristics in patients with marginal zone lymphoma in an attempt to distinguish those prone to a worse outcome, as well as a higher risk for transformation to an aggressive lymphoma. Furthermore, he is also involved in studies utilizing molecular imaging in the risk stratification of lymphoma patients, with the goal of developing strategies for individualize care.

Hematologic oncologist C. Ola Landgren, MD, PhD, is the Chief of the Myeloma Program and the inaugural leader of a new research program, Experimental Therapeutics, at Sylvester Comprehensive Cancer Center at the University of Miami Health System and the Miller School of Medicine. Dr. Landgren, previously served as Chief of Myeloma Service at Memorial Sloan Kettering Cancer Center and Professor of Medicine at Cornell Medical College in New York City.

Namrata Chandhok, M.D. is an Assistant Professor of Clinical Medicine (Hematology) at the University of Miami Miller School of Medicine/ Sylvester Comprehensive Cancer Center. She received her MD from the George Washington University School of Medicine in Washington, D.C, completed her residency in Internal Medicine at Tufts Medical Center in Boston, MA and fellowship in Hematology/ Oncology at Yale University School of Medicine/ Yale New Haven Hospital in New Haven, CT. 

Dr. Chandhok specializes in the management of myeloid disorders, which include myelodysplastic syndrome (MDS), myeloproliferative neoplasms (MPN) and acute myeloid leukemia (AML). Her research focuses on the use of novel therapies to treat cancer and identification of cancer dependencies and vulnerabilities in the early stages of cancer that can be used to develop cancer prevention strategies.  She is also deeply invested in advancing health equity in cancer care.

Dr Alencar is an Associate Professor of Clinical Medicine and the Associate Chief Medical Officer at University of Miami Sylvester Comprehensive Cancer Center. He is a member of the lymphoma program at Sylvester and the lymphoma committee at the Alliance for Clinical Trials in Oncology with a focus on clinical research of b-cell lymphoid malignancies with special interest in minorities, particularly elderly and Hispanics. His research focuses on the application of novel agents to improve responses and minimize toxicity on the care of elderly patients. As the hematology section lead for the Sylvester鈥檚 Global Oncology Program, Dr Alencar serves as an important bridge to the United States for Latin American hematologists being a constant presence in meetings, lectures, as well as direct patient care through international tumor boards and second opinions. These collaborations have led to a large multinational study evaluating the impact of genetic mutations and ancestry on outcomes of Hispanic patients with blood disorders.

Dr. Moskowitz is an International expert in Lymphoma whose research focuses on Hodgkin Lymphoma, diffuse large B cell lymphoma and mantle cell lymphoma incorporating molecular and radiologic imaging models. Investigational therapy focuses on the use of new drugs including, targeted therapy, checkpoint inhibitors, antibody-drug conjugates and cellular therapy. In addition, as Physician in Chief and Deputy Cancer Center Director at the Sylvester Comprehensive Cancer Center he oversees all oncologic Care focusing on the use of evidence-based medicine, interventional clinical trials and precision medicine to optimize the management of all subtypes of cancer.

Ariane Middel is an urban climatologist whose work has greatly advanced scientists鈥� understanding of the effects of urban heat islands. 

She is currently focused on developing better models and metrics to quantify urban heatscapes using tools like MaRTy, a biometeorological robot designed to measure extreme temperatures and how the body reacts to heat. MaRTy stands for mean radiant temperature. The robot was used in one of Middel鈥檚 latest studies on ASU鈥檚 Tempe campus where her team measured the best landscape designs to keep people cool.

Middel is an assistant professor in both the School of Geographical Science and Urban Planning and the School of Arts, Media and Engineering. She is also a member of the Urban Climate Research Center and the Central Arizona鈥揚hoenix Long-Term Ecological Research program at ASU.

She is currently serving a 4-year term (2016-2020) on the Board of the International Association of Urban Climate and is also a member of the American Meteorological Society, the International Society of Biometeorology and the Institute of Electrical and Electronics Engineers.

James Sulikowski researches the migration and metabolism of aquatic animals, specializing in sharks. 

He has worked with fisheries to observe the impact of chronic stress variables on their biological functions. This has evolved to testing neurotransmitter efficiency and protein regulation among different species.

His work further extends to utilizing telemetry, ultrasound and other tracking methods to observe how fish have adapted their migration patterns around human impacts.

Sulikowski is an associate director and professor for the School of Mathematical and Natural Sciences as well as the School of Life Sciences Interdisciplinary Graduate Faculty.

His work has been featured on Discovery Channel鈥檚 鈥淪hark Week,鈥� NBC鈥檚 鈥淭oday Show,鈥� National Geographic 鈥淥cean Mysteries with Jeff Corwin,鈥� and the BBC series 鈥淩ise of Animals.鈥�

Dr Sekeres has focused on leukemias, and particularly myelodysplastic syndromes and acute myeloid leukemia in older adults, for two decades. He has developed innovative therapies for these cancers; helped define the genetics of leukemia and related blood and bone marrow cancers along with clinical correlates; helped redefine prognostication, including innovative methods using machine learning and artificial intelligence; and helped define the epidemiology and patient reported outcomes in these conditions. He has also chaired the FDA’s Oncologic Drugs Advisory Committee and is an expert on cancer regulatory issues, and is a widely published essayist focused on patient-doctor communication, with 60 essays in The New York Times.

Clinical research in the field of plasma cell disorders, such as amyloidosis and multiple myeloma.

Specialties: Hematologic Malignancy, Hematology Oncology

Areas of Expertise: Myeloma, Amyloidosis, POEMS, Monoclonal gammopathy, MGUS

Age Groups Seen: Adolescents (ages 12-18), Adults

David S. Perlin, Ph.D. is Chief Scientific Officer and Senior Vice President of the Center for Discovery and Innovation (CDI); Professor of Medical Sciences at the Hackensack Meridian School of Medicine; Fellow of the New York Academy of Sciences; and Fellow of the American Academy of Microbiology.

His research emphasizes studies to diagnose and overcome drug-resistant fungal and bacterial infections in cancer, transplant and other high-risk patients by exploiting insights obtained from molecular investigations of drug resistance, pathogenicity, and host response to improve current therapies and develop novel drugs and diagnostics. During COVID-19, Perlin and his CDI colleagues were instrumental in developing new diagnostics for the virus and its variants, as well as investigating the potential of convalescent plasma and other therapies. 

David Souleles, MPH, is the Director of the COVID-19 Response Team at the University of California, Irvine. He is also the Director of the Masters in Public Health (MPH) Program and Practice for the UCI Program in Public Health. He has over 25 years of experience leading public health agencies at local, regional and state levels.

Craig Hardgrove's research focuses on thermal infrared and nuclear remote sensing of the moon and Mars.

He is the principal investigator of the LunaH-Map mission, the first planetary science mission designed, built and operated by ASU. The LunaH-Map CubeSat mission will orbit the moon to map hydrogen-rich deposits in permanently shadowed regions.

Hardgrove has experience working on many Mars rover and orbiter missions and is a collaborator on the Mars Science Laboratory rover's DAN instrument. He is working to develop next-generation neutron and gamma ray detectors, specifically on small spacecraft like CubeSats.

His research specialties include remote sensing of terrestrial and other planetary surfaces, spacecraft instrument development, Mars surface geology and improving planetary rover software by incorporating thermal infrared imaging and machine learning. His organization, Astrum Terra, aims to bring real science data from planetary spacecraft to the video game industry.

Charles Rolsky researches marine and aquatic plastic pollution, a major concern within many ecosystems and environments around the world.

Rolsky also works on using non-invasive research methods to collect species health information, including fecal samples from wild species like killer whales. Having this information provides significant knowledge pertaining to stress, reproduction and overall species health.

As graduate teaching assistant with the Biodesign Institute, he collaborates with Fulton School of Engineering on several microplastics projects, in addition to many groups worldwide, including Plastic Oceans.

Charles Katz is an expert in criminology, criminal justice and gang violence.
Katz is Watts Endowed Family Chair and a Professor in the School of Criminology and Criminal Justice and is Director of the Center for Violence Prevention and Community Safety.

Much of his research focuses on gangs and strategic responses to community gang problems. He served as the principal investigator for an NIJ funded project examining the police response to gangs in four cities: Phoenix, Arizona, Albuquerque, New Mexico, Las Vegas Nevada, and Inglewood, California. 

Related to this research, Dr. Katz spent over 2,000 hours in the field with gang unit officers across the country, examining organizational structures and operational strategies that are effective in responding to gangs.

His work has also been funded by the U.S. Department of Homeland Security to examine the size, scope, and organizational structure of MS13.